A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations

This randomized, double-blind controlled trial of everolimus in individuals with germline phosphatase and tensin homolog mutations (PTEN) was designed to evaluate the safety of everolimus compared with placebo and to evaluate the efficacy of everolimus on neurocognition and behavior compared to plac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardan, Antonio Y., Jo, Booil, Frazier, Thomas W., Klaas, Patricia, Busch, Robyn M., Dies, Kira A., Filip-Dhima, Rajna, Snow, Anne V., Eng, Charis, Hanna, Rabi, Zhang, Bo, Sahin, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887633/
https://www.ncbi.nlm.nih.gov/pubmed/33644493
http://dx.doi.org/10.1016/j.conctc.2021.100733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887633/
https://www.ncbi.nlm.nih.gov/pubmed/33644493
http://dx.doi.org/10.1016/j.conctc.2021.100733

Ejemplares similares